BKMIX
Price
$10.68
Change
+$0.04 (+0.38%)
Updated
Jun 18 closing price
Net Assets
10.5B
FCANX
Price
$13.28
Change
+$0.08 (+0.61%)
Updated
Jun 18 closing price
Net Assets
2.27B
Interact to see
Advertisement

BKMIX vs FCANX

BKMIX vs FCANX Comparison Chart in %
View a ticker or compare two or three
VS
BKMIX vs. FCANX commentary
Jun 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKMIX is a Hold and FCANX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BKMIX has more cash in the bank: 10.5B vs. FCANX (2.27B). BKMIX pays higher dividends than FCANX: BKMIX (5.96) vs FCANX (1.83). BKMIX was incepted earlier than FCANX: BKMIX (9 years) vs FCANX (19 years). FCANX (1.55) is less costly to investors than BKMIX (0.62). BKMIX is a more actively managed with annual turnover of: 99.00 vs. FCANX (24.00). FCANX has a lower initial minimum investment than BKMIX: FCANX (0) vs BKMIX (5000000). FCANX annual gain was more profitable for investors over the last year : 12.79 vs. BKMIX (10.30). BKMIX return over 5 years is better than : 23.29 vs. FCANX (15.03).
BKMIXFCANXBKMIX / FCANX
Total Expense Ratio0.521.5234%
Annual Report Gross Expense Ratio0.621.5540%
Fund Existence9 years19 years-
Gain YTD3.7755.56368%
Front LoadN/AN/A-
Min. Initial Investment50000000-
Min. Initial Investment IRAN/A500-
Net Assets10.5B2.27B462%
Annual Yield % from dividends5.961.83326%
Returns for 1 year10.3012.7981%
Returns for 3 years15.3121.3472%
Returns for 5 years23.2915.03155%
Returns for 10 yearsN/A42.82-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ILCG117.142.24
+1.95%
iShares Morningstar Growth ETF
DUNK24.480.31
+1.28%
Dana Unconstrained Equity ETF
AIVL128.881.05
+0.82%
WisdomTree US Al Enhanced Val ETF
ZOCT27.590.04
+0.15%
Innovator Eq Dfnd Prt ETF - 1 Yr Oct
BIB85.020.07
+0.08%
ProShares Ultra Nasdaq Biotechnology